First Manhattan CO Catalyst Biosciences, Inc. Transaction History

First Manhattan CO

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Aug 16, 2019	SELL	$7.08 - $10.6 $1.81 Million - $2.72 Million	-256,284 Closed	0 $0
Q3 2018 Oct 15, 2018	BUY	$9.35 - $12.44 $2.4 Million - $3.19 Million	256,284 New	256,284 $2.76 Million

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.